




Int. J. Mol. Sci. 2021, 22, 9364. https://doi.org/10.3390/ijms22179364 www.mdpi.com/journal/ijms 
Article 
Mitogen Kinase Kinase (MKK7) Controls Cytokine Production 
In Vitro and In Vivo in Mice 
Amada D. Caliz 1, Hyung-Jin Yoo 1, Anastassiia Vertii 2, Ana C. Dolan 1, Cathy Tournier 3, Roger J. Davis 4,  
John F. Keaney, Jr. 1 and Shashi Kant 1,* 
1 Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital,  
Harvard Medical School, Boston, MA 02115, USA; acaliz@partners.org (A.D.C.);  
hyoo@bwh.harvard.edu (H.-J.Y.); acdolan@bwh.harvard.edu (A.C.D.); jfkeaney@bwh.harvard.edu (J.F.K.J.) 
2 Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School,  
Worcester, MA 01655, USA; anastassiia.vertii@umassmed.edu 
3 Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health,  
University of Manchester, Manchester M13 9PL, UK; cathy.tournier@manchester.ac.uk 
4 Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01655, USA; 
roger.davis@umassmed.edu 
* Correspondence: skant1@bwh.harvard.edu 
Abstract: Mitogen kinase kinase 4 (MKK4) and mitogen kinase kinase 7 (MKK7) are members of the 
MAP2K family that can activate downstream mitogen-activated protein kinases (MAPKs). MKK4 
has been implicated in the activation of both c-Jun N-terminal kinase (JNK) and p38 MAPK, while 
MKK7 has been reported to activate only JNK in response to different stimuli. The stimuli, as well 
as the cell type determine which MAP2K member will mediate a given response. In various cell 
types, MKK7 contributes to the activation of downstream MAPKs, JNK, which is known to regulate 
essential cellular processes, such as cell death, differentiation, stress response, and cytokine secre-
tion. Previous studies have also implicated the role of MKK7 in stress signaling pathways and cy-
tokine production. However, little is known about the degree to which MKK4 and MKK7 contribute 
to innate immune responses in macrophages or during inflammation in vivo. To address this ques-
tion and to elucidate the role of MKK4 and MKK7 in macrophage and in vivo, we developed MKK4- 
and MKK7-deficient mouse models with tamoxifen-inducible Rosa26 CreERT. This study reports that 
MKK7 is required for JNK activation both in vitro and in vivo. Additionally, we demonstrated that 
MKK7 in macrophages is necessary for lipopolysaccharide (LPS)-induced cytokine production, M1 
polarization, and migration, which appear to be a major contributor to the inflammatory response 
in vivo. Conversely, MKK4 plays a significant, but minor role in cytokine production in vivo. 
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1. Introduction 
The mitogen-activated protein kinases (MAPKs) are an evolutionarily conserved sig-
naling mechanism that controls a range of important cellular functions, including differ-
entiation, stress response, and apoptosis [1,2]. Stress-activated MAPK is comprised of two 
major pathways, c-Jun N-terminal kinase (JNK) and p38 MAP kinase (p38) [3]. JNK and 
p38 are well-studied signaling cascades that are essential for vital cellular activities [4,5]. 
The activation of MAPK JNK and p38 are mediated by several members of the evolution-
ary conserved upstream mitogen-activated protein kinases kinase (MAP2K) family [6–8]. 
Such diversity in the repertoire of upstream activators might, in turn, define the specificity 
of the stimuli-induced pathway activation. 
Both mitogen kinase kinase 4 (MKK4) and mitogen kinase kinase 7 (MKK7) are 
MAP2K family members. While MKK4 has been implicated in the activation of both 
downstream stress-activated MAPKs, JNK and p38 [3,4,9,10], MKK7 mainly activates the 
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downstream kinase JNK in the presence of different stimuli [3,4]. The cell type and acti-
vation stimuli determine whether MAP2K, MKK7 or MKK4, plays a significant role in the 
downstream targets of JNK and p38 activation in vitro and in vivo [11–13]. 
The innate immune response is an evolutionarily conserved response and the first 
line of defense against harmful pathogens [14]. The inflammatory response is a well-or-
chestrated event initiated by pathogens, such as bacteria, and mediated by a quick activa-
tion of MAPK, leading to the production of cytokines. This MAPK activated cytokine pro-
duction leads to the amplification of an inflammatory response that affects both the im-
mune and non-immune cells [15]. Understanding the cell-type- and stimuli-specific mech-
anisms responsible for the signal transduction is essential for managing the uncontrolled 
inflammatory responses. The precise contribution of MKK4 and MKK7 in the macro-
phage-specific immune response has not been discerned. Using both in vivo and in vitro 
models, we determined the contribution of each kinase with respect to downstream target 
activation, cytokine secretion, and macrophage migration, all essential features of an ef-
fective immune response. 
Pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNFα) and bacte-
rial lipopolysaccharides (LPS), activate MAPKs, JNK, and p38 [16]. However, it is unclear 
which MAP2K plays a more prominent role during TNFα and LPS activation of JNK and 
p38 in macrophages. The purpose of this study is to determine whether MKK4 or MKK7 
plays a critical role in JNK activation and cytokine production during inflammation in 
macrophages. In this study, we have shown that MKK7 plays a major role in TNFα and 
LPS-activated JNK signaling and cytokine production in vitro and in vivo. Although 
MKK4 contributes to LPS mediated inflammatory response in macrophages, its effects on 
the JNK signaling and cytokine production are modest compared to MKK7. Data from 
this study indicate that the MKK7 pathway represents a potential target for developing 
therapeutic drugs that may be beneficial for the treatment of sepsis and inflammation. 
2. Results 
2.1. Conditional MKK7 Mice Generation 
JNK kinases can be activated by different MAP2Ks, which include MKK4 and MKK7 
proteins [2,17]. p38 MAPK can be activated mainly by MKK3 and MKK6, but MKK4 can 
play a role in some circumstances [9]. However, the role of MKK7 in the activation of p38 
MAPK is not known. Previously, we have established the role of mixed lineage kinases 
(MLKs), a member of mitogen-activated protein kinases kinase kinase (MAP3K) family in 
TNFα and LPS-activated JNK and p38 MAPKs in vitro and in vivo [4,16,18]. MLKs also 
regulate cytokine production in vitro and in vivo [4,16]. Additionally, activation of JNK 
and p38 via MKK4 and MKK7 have been implicated in cytokine production [11]. None-
theless, the roles of MKK4 and MKK7 in LPS-induced macrophages and inflammation are 
not known. To investigate the role of MKK4 and MKK7 in LPS-induced cytokine produc-
tion in vivo, we used our previously published MKK4 conditional mice [19] and generated 
MKK7 conditional mice (Supplementary Figure S1). More specifically, the temporal dele-
tion in MKK4 and MKK7 mice was achieved by crossing MKK4-floxed and MKK7-floxed 
mice with inducible Rosa26-CreERT mice (Supplementary Figure S1). Genotypic analysis 
utilizing different tissues isolated from tamoxifen-treated Rosa26-CreERT-Mkk4-floxed 
(Mkk4∆/∆) and Rosa26-CreERT-Mkk7-floxed (Mkk7∆/∆) mice demonstrated the specific disrup-
tion of the Mkk4 and Mkk7 genes (Supplementary Figure S1), which was not observed in 
control mice. This finding was confirmed by immunoblot analysis of MKK4 and MKK7 
expression in mouse embryonic fibroblasts (MEFs) isolated from control or Mkk4∆/∆ and 
Mkk7∆/∆ mice treated with 4-hydroxytamoxifen (Supplementary Figure S1). 
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2.2. MKK7 is Required for TNFα-Stimulated MAP Kinase Activation 
A pro-inflammatory cytokine TNFα binds to TNFα receptors (TNFR) on the cell sur-
face which activates the signal transduction mechanisms leading to the phosphorylation 
of MKK4 and MKK7 protein kinases [11]. We used primary mouse embryonic fibroblast 
cells (MEFs) treated with TNFα to examine the contribution of MKK4 and MKK7 to JNK 
and p38 MAPK activation. First, we isolated MEFs from control or Rosa26-CreERT-Mkk4-
floxed and Rosa26-CreERT-Mkk7-floxed mice. These isolated MEFs were treated with 4-hy-
droxytamoxifen for specific gene deletion. Using these MKK4 and MKK7 knockout MEFs, 
we assessed the contribution of MKK4 and MKK7 in MEFs by stimulating these cells with 
TNFα and compared them to Rosa26 CreERT control cells. We found that a deficiency of 
MKK4 caused only minor changes in TNFα-stimulated MAP kinase activation of JNK 
(Figure 1A). Conversely, TNFα-stimulated MAP kinase activation of JNK in Mkk7∆/∆ MEFs 
was markedly reduced (Figure 1A). 
 
Figure 1. TNFα causes activation of the MKK7 signal transduction pathway. (A) Mouse embryonic 
fibroblast cells (MEFs) isolated from Rosa26-CreERT, Rosa26-CreERT-Mkk4-floxed, and Rosa26-CreERT-
Mkk7-floxed conditional mice were treated with the 4-hydroxytamoxifen for respective gene dele-
tion. 5 days post deletion, MEFs were treated with or without 10 ng/mL TNFα across three-time 
points (in minutes). MAP kinase JNK and p38 activation were examined by immunoblot analysis. 
(B) Bone marrow drives primary macrophages (BMDMs) from different genotypes were treated 
with or without 10 ng/mL TNFα across three-time points (in minutes). JNK and p38 MAPK activa-
tion were examined by immunoblot analysis. All relative quantification values of western blots were 
measured in comparison to control. All the experiments were repeated 3–4 times. 
Next, bone marrow-derived primary macrophages (BMDMs) isolated from Rosa26-
CreERT-Mkk4-floxed and Rosa26-CreERT-Mkk7-floxed conditional mice were treated with 4-
hydroxytamoxifen for respective gene deletion. Similar to the MEFs, treatment with TNFα 
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to MKK4-deficient BMDMs caused only minor changes in TNFα-stimulated JNK activa-
tion (Figure 1B). However, TNFα-stimulated JNK activation was severely affected by 
MKK7 deficiency compared to the controls (Figure 1B). We also observed a minor change 
in the activation of p38 MAPK in both MKK4 and MKK7-deficient BMDMs. Together, 
these data indicate that the majority of TNFα-stimulated MAP kinase activation is medi-
ated by MKK7, while MKK4 acts as a minor partner. 
2.3. MKK7 Plays an Important Role in LPS-Induced MAP Kinase Activation and  
Cytokine Production 
To further examine the individual contributions of MKK4 and MKK7 in LPS-induced 
MAPK activation in macrophages, we compared the responses of JNK and p38 activation 
in wild-type control, Mkk4∆/∆ and Mkk7∆/∆ BMDMs to LPS treatment. Our data showed that, 
similar to TNFα-induced MEFs, MKK4 deficiency produces only a moderate decrease in 
JNK and p38 activation in LPS-induced macrophages (Figure 2). In contrast, LPS-induced 
MKK7-deficient macrophages showed a significant reduction in both JNK and p38 activa-
tion (Figure 2). 
 
Figure 2. Effect of MKK4 or MKK7-deficiency on the response to LPS. BMDMs isolated from Rosa26-
CreERT, Rosa26-CreERT-Mkk4-floxed, and Rosa26-CreERT-Mkk7-floxed conditional mice were treated 
with 4-hydroxytamoxifen for respective gene deletion. 5 days post deletion, BMDMs were treated 
with or without 100 ng/mL LPS for 10, 30, and 60 min. Protein extracts were examined by immunob-
lot analysis by probing with antibodies to MAP kinases and phospho-MAP kinases. All relative 
quantification values of western blots were measured in comparison to control. All the experiments 
were repeated 3–4 times. 
Next, we compared the production of inflammatory cytokines during LPS treatment 
in control, MKK4, and MKK7-deficient BMDMs. We found that both LPS-treated MKK4 
and MKK7- deficient BMDMs secrete markedly less TNFα and interleukin 6 (IL6) than the 
wild-type control cells (Figure 3A). However, the reduction in cytokine production was 
significantly higher in Mkk7∆/∆ than Mkk4∆/∆ (Figure 3A). We also analyzed mRNA produc-
tion of pro-inflammatory cytokines TNFα and IL6 in both MKK4 and MKK7- deficient 
BMDMs. Similar to the secreted cytokines proteins, mRNA expression was compromised 
in both MKK4 and MKK7-deficient BMDMs when compared to control cells. Consistent 
with cytokine secretion, the effect of MKK7-deficiency caused a greater decrease in TNFα 
and IL6 cytokine expression than MKK4-deficiency in BMDMs (Figure 3B). Collectively, 
these data show that MKK4 and MKK7 are required for cytokine production in LPS-in-
duced macrophages, with MKK7 having a stronger impact on pro-inflammatory cyto-
kines at the mRNA and protein levels. 




Figure 3. The MKK4 and MKK7 pathway contribute to LPS-stimulated and cytokine production in macrophages. (A,B) 
Rosa26-CreERT, Mkk4∆/∆ and Mkk7∆/∆ BMDMs were treated with 100 ng/mL LPS. The amount of TNFα and IL6 in the culture 
medium was measured by ELISA (A), and RT-qPCR was performed to measure mRNA production of TNFα and IL6 (B) 
(mean ± S.E.M.; n = 6–8). Statistically significant differences between groups are indicated. (*) p < 0.05; (**) p < 0.01; (***) p 
< 0.001 vs. WT. All the experiments were repeated 3–4 times. 
2.4. MKK 7 Controls Cell Migration 
MAPK signaling has been implicated in macrophage migration and invasion. 
Healthy macrophages require robust migration and invasion to execute their proper func-
tion; thus, highlighting the importance of determining the role of MKK4 and MKK7 in 
macrophage migration and invasion. We found that MKK4 deficiency leads to a modest 
disruption of cell migration and invasion in macrophages (Figure 4), while MKK7-defi-
ciency produced a major blockage in the migration and invasion of macrophages com-
pared to the control (Figure 4). These data demonstrate that MKK7 is a key component of 
macrophage migratory machinery. 
 
Figure 4. Role of MKK4 and MKK7 in cell migration and invasion. (A,B) A Transwell system was used to measure the 
migration (A) and Matrigel invasion assay (B) of Rosa26-CreERT, Mkk4∆/∆ and Mkk7∆/∆ BMDMs. (mean ± S.E.M.; n = 8); (*) p 
< 0.05 vs. WT. All the experiments were repeated 3–4 times. 
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2.5. MKK7 Contributes to Inflammatory Cytokine Production In Vivo 
To examine the contribution of MKK4 and MKK7 to the immune response in vivo, 
we tested the effects of MKK4 and MKK7 deficiency on the response of mice to endotoxin 
exposure. Control Rosa26-CreERT, Rosa26-CreERT-Mkk4-floxed and Rosa26-CreERT-Mkk7-
floxed conditional mice were injected with a single dose of tamoxifen for respective gene 
deletion. After 2 weeks of gene deletion, all three group of mice injected with endotoxin 
LPS. Treatment of wild-type mice with LPS caused increased production of inflammatory 
cytokines TNFα, IL6, IL1α, and IL1β in the blood (Figure 5). Although, the production of 
LPS-induce pro-inflammatory cytokines TNFα, IL6, IL1α, and IL1β were significantly 
suppressed in both Mkk4∆/∆ and Mkk7∆/∆ mice in comparison to wild-type control mice 
(Figure 5).  
However, this decreases in cytokine production in both Mkk4∆/∆ and Mkk7∆/∆, mice 
were significantly lower compared to the control, the decrease in cytokines TNFα, IL6, 
IL1α, and IL1β production in MKK4-deficient BMDMs were less compared to MKK7-de-
ficient mice (Figure 5). Together, these data establish the MKK4 and MKK7 pathways as 
contributors to inflammation and, like isolated macrophages in vitro, suggested that 
MKK7 has a significantly stronger contribution to the LPS response than MKK4 in vivo. 
 
Figure 5. The MKK4 and MKK7 pathway contribute to LPS-mediated inflammation. Rosa26-CreERT, Mkk4∆/∆, and Mkk7∆/∆ 
mice were treated with or without 20 mg/kg LPS by intraperitoneal injection (2 h). The amount of TNFα, IL6, IL1α, and IL1β 
in the serum was measured by ELISA (SE; n = 8). Statistically significant differences between wild-type and MLK-deficient 
mice are indicated. (mean ± S.E.M.; n = 8); (*) p < 0.05; (**) p < 0.01 vs. WT. All the experiments were repeated 3–4 times. 
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2.6. MKK7 is Required for M1 Macrophage Polarization 
Macrophage polarization plays an important role during inflammation [20]. The 
macrophage can polarize into inflammatory (M1) or anti-inflammatory (M2) macro-
phages according to their microenvironment and perform different functions [20,21]. To 
determine if MKK7 is required for macrophage polarization, we performed an M1 and M2 
polarization experiment in controls, Mkk4∆/∆ and Mkk7∆/∆ BMDMs. After polarization to ei-
ther M1 and M2 macrophages, we performed RT-qPCR to check the expression of markers 
for M1 (TNFα) and M2 (IL6) macrophages in isolated BMDM cells of the controls, Mkk4∆/∆ 
and Mkk7∆/∆ mice. Results from RT-qPCR analysis demonstrated that macrophage-specific 
MKK7-deficiency decreased the expression of M1 marker genes (TNFα) in comparison to 
the controls (Figure 6A). Moreover, gene expression associated with M2 polarization (IL10) 
demonstrated that macrophage-specific MKK7-deficiency increased the expression of 
genes associated with M2 polarization (Figure 6B). These data confirm that MKK7 expres-
sion in macrophages promotes M1 polarization and suppresses M2 polarization. 
 
Figure 6. MKK7 is required for macrophages polarization. (A) Total RNA was isolated from BMDM incubated (8 h) with-
out or with 100 ng/mL IFNγ. The relative mRNA expression of M1 (TNFα) and M2 (IL10) markers were measured by RT-
qPCR assays. (B) Total RNA was isolated from BMDM incubated with, or without, 10 ng/mL IL4 (24 h). The relative mRNA 
expression of the M1 (TNFα) and M2 (IL10) markers were measured by RT-qPCR assays. Statistically significant differ-
ences between groups are indicated (mean ± S.E.M.; n = 4–6; * p < 0.05). All the experiments were repeated 3–4 times. 
2.7. JNK1/2 Mimics the Phenotype of MKK7 during Inflammatory Cytokine Production In Vitro 
JNK signaling is severely affected by MKK7- deficiency (Figure 1). To dissect the role 
of JNK1/2 in macrophages, we isolated BMDMs from control Rosa26-CreERT and Rosa26-
CreERT-Jnk1-floxed Jnk2−/− mice and treated them with 4-hydroxytamoxifen for gene dele-
tion (Jnk1∆/∆Jnk2−/−). These control Rosa26-CreERT and Jnk1∆/∆Jnk2−/− macrophages were 
treated with LPS for 24 h. Similar to MKK7, LPS-treated JNK1/2- deficient BMDMs secrete 
markedly less TNFα and IL6 than wild-type cells (Figure 7A). 
Thereafter, we tested the mRNA expression of the pro-inflammatory cytokines, 
TNFα and IL6, in JNK1/2- deficient BMDMs. We found that similar to the secreted cyto-
kines, mRNA expression of TNFα and IL6 were reduced in JNK1/2- deficient BMDMs 
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compared to the control cells (Figure 7B). These data suggest that JNK1/2 is required for 
cytokine production in LPS-induced macrophages. 
Next, the role of the MKK7 downstream target, JNK, during the migration and inva-
sion of macrophages was investigated. We used macrophages isolated from control and 
Jnk1∆/∆Jnk2−/− for these experiments. Similar to MKK7-deficiency, JNK1/2-deficiency in 
macrophages leads to a significant reduction of macrophage migration and invasion (Fig-
ure 7C). These data show that JNK1/2-deficient macrophages mimic the phenotype of 
MKK7 during macrophage migration. 
Going forward, we also investigated the role of the JNK during M1 and M2 polariza-
tion of macrophages by using the macrophages isolated from control and Jnk1∆/∆Jnk2−/− 
mice. Similar to MKK7-deficiency, JNK1/2-deficiency in macrophages leads to a signifi-
cant reduction of M1 polarization and increases the M2 polarization of macrophages (Fig-
ure 7D,E). These all data confirm that MKK7 and JNK1/2 have overlapping function in 
macrophages and inflammation. 
 
Figure 7. The JNK1/2 mimics the MKK7 phenotype and contributes to LPS-stimulated and cytokine production in macro-
phages. (A,B) Rosa26-CreERT and Jnk1∆/∆ Jnk2−/− BMDMs were treated with 100 ng/mL LPS. The amount of TNFα and IL6 in 
the culture medium was measured by ELISA (A), and RT-qPCR was performed to measure mRNA production of TNFα 
and IL6 (B). (C) Rosa26-CreERT, Jnk1∆/∆ Jnk2−/− BMDMs were used to measure the migration and Matrigel invasion assay by 
the Transwell system. (D) Total RNA was isolated from BMDM incubated (8 h) without or with 100 ng/mL IFNγ. The 
relative mRNA expression of M1 (TNFα) and M2 (IL10) markers were measured by RT-qPCR assays. (E) Total RNA was 
isolated from BMDM incubated without or with 10 ng/mL IL4 (24 h). The relative mRNA expression of the M1 (TNFα) 
and M2 (IL10) markers were measured by RT-qPCR assays. (mean ± S.E.M.; n = 6). Statistically significant differences 
between groups are indicated. (*) p < 0.05; (**) p < 0.01; (***) p < 0.001 vs. WT. All the experiments were repeated 3–4 times. 




The MKK4 and MKK7 pathways are mediators of cytokine signaling, which results 
in JNK and p38 MAPK activation, leading to the transcriptional activation of cytokine 
genes and, eventually, cytokine production [3,11]. Biochemical studies using cultured pri-
mary cells have provided substantial evidence to support this conclusion [6,11]. However, 
mice lacking mkk4 or mkk7 die [6,8,11,22] before birth, making it difficult to determine the 
role of MKK4 and MKK7 in vivo. Therefore, there has been limited research investigating 
the roles of MKK4 and MKK7 in vivo. To overcome this problem, in this study, we gener-
ated conditional MKK4 and MKK7 knockout mice to examine the roles and contributions 
of the MKK4 and MKK7 pathways in macrophage activation and cytokine production in 
vitro and in vivo. 
Dissecting the cell type-specific mechanisms that dominate the innate immune re-
sponse is critical for the successful management strategies of the uncontrolled inflamma-
tory response [14,23]. Notably, our in vitro and in vivo data showed that, during LPS-
induced cytokine production, MKK7 plays a major role in comparison to MKK4. Our data 
demonstrated that MKK7 regulates cell polarization and migration, an essential feature of 
efficient macrophage functionality. The ability of MKK7 to control polarization and mi-
gration of macrophages suggests that MKK7 can regulate inflammation. We also observed 
that JNK knockout mimics the LPS-induced cytokine phenotype caused by MKK7 defi-
ciency. Although unlike cytokine production data our polarization data showed that 
MKK7 knockout varies a bit in the phenotype with JNK1/2 macrophage (Figures 6A,B and 
7D,E). It can be explained either by some role of MKK7 in p38 activation or JNK family 
member JNK3 may present in macrophage and play some role. 
MAPK and Nuclear factor-κB (NFκB) pathways both play an essential role in cyto-
kine production [24]. Specifically, both innate immune and adaptive cells, such as macro-
phages and T-cells produce various pro-inflammatory cytokines in a MAPK-dependent 
manner during infection, causing an inflammatory response. 
JNK requires phosphorylation on both Thr180 and Tyr182 for its complete activation 
[6]. JNK phosphorylation occurs preferentially on Tyr182 by MKK4 and on Thr180 by 
MKK7 [11,25]. Additionally, it is known that both MKK4 and MKK7 are required for opti-
mal activation of JNK in fibroblast [6,11]. MKK4 and MKK7 appear to contribute equally to 
JNK activation in response to UV radiation [6]. However, MKK7 is essential for JNK activa-
tion by TNFα, and MKK4 is only required for maximum JNK activation in MEFs [11]. The 
cooperation between the two kinases, MKK7 and MKK4, may be true in macrophages as 
well, where MKK7 plays a major role in JNK activation, and MKK4 is only required to max-
imize the JNK activation. Although the role of MKK7 in the activation of p38 MAPK has not 
been established, our data showed that MKK7 might play a minor role in p38 MAPK acti-
vation as well. We can speculate that similar to JNK activation, p38 MAPK may require 
MKK7 with its main activator, MKK3/6 [10], for optimal activation in macrophages. 
JNK and p38 are long-studied stress signaling cascades essential for a broad range of 
vital cellular and organismal activities. Therefore, the use of small molecular inhibitors 
against JNK or p38 to prevent cytokine production and inflammation would likely be ac-
companied by severe side effects, making them poor drug targets. Several members of the 
MAP2K and MAP3K tier of kinases were shown to activate JNK and p38 pathways [4,16,26]. 
Such diversity in the repertoire of upstream activators might, in turn, define the specificity 
of the stimuli-related pathway activation. Therefore, the data presented in this manuscript 
suggest that MKK7 plays a vital role in the activation of JNK and the production of TNFα, 
making it a potential drug target in preventing cytokine production and inflammation. 
4. Materials and Methods 
4.1. Animals 
Inducible Rosa26 Cre strain mice were obtained from The Jackson Laboratory 
(004847). Mice with floxed Mkk4 gene [19], floxed Mkk7 (exons 3–6 flanked by LoxP site) 
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[12] and floxed Jnk1 Jnk2−/− [27] were bred with the inducible Rosa26-CreERT mouse line 
on the C57BL/6J background (Supplementary Figure S1). Both mice were injected with a 
single dose of tamoxifen (100 mg/kg body weight in corn oil) for respective gene deletion. 
All mouse experiments were performed according to the relevant ethical regulations. 
Mice were housed in a facility accredited by the American Association for Laboratory An-
imal Care. All animal studies were approved by the Institutional Animal Care and Use 
Committee of the University of Massachusetts Medical School and the Brigham Women’s 
Hospital, Boston, MA, USA. 
4.2. Cell Culture 
Bone marrow-derived primary macrophages (BMDMs) were prepared by flushing 
the bone marrow cells from the femur and tibia of mice using a 23 G needle. The cells were 
cultured in a medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 20% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM 
sodium pyruvate, 0.1 mM nonessential amino acids, 100 U/mL penicillin, and 100 ug/mL 
streptomycin (Life Technologies, Grand Island, NY, USA) in the presence of 30% super-
natant from L929 cells as a source of macrophage colony-stimulating factor (M-CSF1; 10–
50 ng/mL). After 3–4 days of culture, non-adherent cells were removed, and adherent 
monolayers were washed in PBS and incubated in fresh media. Experimental cells were 
resuspended by gently scraping into ice-cold PBS, then cultured in DMEM with 1% FBS, 
100 U/mL penicillin, and 0.1 mg/mL streptomycin. Polarization studies were performed 
using macrophages (7–10 days in culture) incubated with 100 ng/mL IFNγ or 10 ng/mL 
LPS (M1) for 8 h or 10 ng/mL IL4 (M2) for 24 h. 
Primary mouse embryonic fibroblast cells (MEFs) were isolated by dissecting 13.5 
days of embryos. After the dissection of embryos, the brain and dark red organs were 
removed. Using razor blades and a small amount of PBS, embryos were minced. After 
mincing 5 mL of 0.05% trypsin-EDTA (Gibco) was added to the suspended cells/tissue. The 
cells/tissue were then incubated at 37 °C, with gentle shaking with 5 mm glass beads, for 15 
min. Isolated primary MEFs were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum, 100 U/mL penicillin, 100 ug/mL streptomycin, and 2 
mM L-glutamine (Life Technology).  
Both BMDMs and MEFs isolated from different genotyped mice were treated with 4-
hydroxytamoxifen (2 uM) for 24 h for respective gene deletion. Cells were used for exper-
iments after 5 days of 4-hydroxytamoxifen treatment. 
4.3. Cell Migration and Invasion Assays 
BMDMs with serum-free cell culture media were plated (100 μL) on top of the filter 
membrane in a transwell insert and incubated for 10 min at 37 °C and 5% CO2 to allow the 
cells to settle down (Corning, Corning, NY, USA). After 10 min, 600 μL of the DMEM 
media with monocyte chemoattractant protein 1 (MCP1) chemoattractant (10 uM) were 
added into the bottom of the lower chamber in a 24-well plate. Transwell inserts were 
removed from the plate and cleaned using a cotton-tipped applicator. Afterward, the 
transwell inserts were placed into 70% ethanol for 10 min to allow cell fixation. Cells were 
incubated in 0.2% crystal violet at room temperature for 5–10 min. After incubation, 
transwell inserts were gently washed in PBS. An inverted microscope was used to count 
the migrating cells. For the invasion assay, Matrigel was thawed until liquified on ice, and 
then 50 μL of Matrigel was added to a 24-well transwell insert and solidified in a 37 °C 
incubator for 15–30 min to form a thin gel layer before cells were plated [28].  
4.4. RNA Preparation and Quantitative Polymerase Chain Reaction 
Quantitative RT–qPCR assays (TaqMan© assays) of mRNA expression were per-
formed using a 7500 Fast Real-Time PCR machine (Applied Biosystems, Waltham, MA, 
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USA) with total RNA prepared from cells with an RNeasy mini kit (Qiagen, Hilden, Ger-
many). TaqMan© assays were used to quantitate Il6 (Mm00446190_m1), Tnfα 
(Mm00443258_m1), and GAPDH (4352339E-0904021) mRNA (Applied Biosystems, Wal-
tham, MA, USA). The 2−ΔΔCT method is used for the relative quantification of genes [29,30]. 
Reference gene of GAPDH was used to normalize the PCRs in each sample. 
4.5. Immunoblot Analysis 
Cell extracts were prepared using triton lysis buffer (TLB buffer) [20 mM Tris (pH 
7.4), 1% Triton X-100, 10% Glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM β-Glycerophos-
phate] with proteinase inhibitors (Sigma #11873580001, St. Louis, MO, USA) and phos-
phatase inhibitors (Sigma #4906837001, St. Louis, MO, USA). Protein extracts (50 μg of 
protein) in β-mercaptoethanol containing SDS sample buffer were separated in 4% to 12% 
gradient SDS-polyacrylamide gels (Bio-Rad #456-8094) and transferred to nitrocellulose 
membranes (Bio-Rad #170-4271, Hercules, CA, USA) and incubated with a primary anti-
body with 1:1000 dilution overnight. Membranes were washed in Tris-buffered saline 
(TBS) with 0.1% Tween-20 for three times and incubated in HRP conjugated secondary 
antibody for 1 h. Immunocomplexes were visualized with horseradish peroxidase-conju-
gated secondary antibodies and detected with a Clarity Western ECL substrate (Bio-Rad 
#170-5061, Hercules, CA, USA). Images were acquired on a chemiluminescent imager 
(Bio-Rad Chem-Doc Imaging System, Hercules, CA, USA) and quantified using Image J 
(NIH, Bethesda, MD, USA or Bio-Rad software (Hercules, CA, USA). 
4.6. Analysis of Blood 
Plasma cytokines and cytokines secreted in cell culture media were measured using 
ELISA (Luminex 200; Millipore, Burlington, MA, USA) by following the manufacturer’s 
instructions [31]. 
4.7. Antibodies and Reagents 
Primary antibodies were obtained from Cell Signaling [MKK4 #9152, MKK7 #4172, 
phospho- JNK1/2 (Thr183, Tyr185) #4668, p38 #9212, phospho-p38 (Thr180, Tyr182) #9211, 
and IκBα #4812, Danvers, MA, USA], BD Pharmingen (JNK1/2 #554285, Bedford, MA, 
USA), and Sigma (α-Tubulin #T5168, St. Louis, MO, USA). 
4.8. Statistical Analysis 
All data are expressed as mean ± SE, and the numbers of independent experiments 
are indicated. Statistical comparisons were conducted between 2 groups by use of Student 
t-test or Mann–Whitney U test as appropriate. Multiple groups were compared with either 
1-way Kruskal–Wallis or ANOVA with a post hoc Tukey–Kramer multiple comparisons 
test as indicated in legends. A p value < 0.05 was considered significant. All statistics were 
done using StatView version 5.0 (SAS Institute, Cary, NC, USA) or GraphPad Prism ver-
sion 5 (GraphPad Software, La Jolla, CA, USA). 
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